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vs. 48.3%, p = 0.001), and had lower median admission NIHSS scores (5 vs. 10, p < 0.001) as well as
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Predictors for affected stroke 
territory and outcome of acute 
stroke treatments are different 
for posterior versus anterior 
circulation stroke
H. Handelsmann1, L. Herzog1,2,3, Z. Kulcsar4, A. R. Luft1,5 & S. Wegener1*
Distinct patient characteristics have been proposed for ischaemic stroke in the anterior versus 
posterior circulation. However, data on functional outcome according to stroke territory in patients 
with acute stroke treatment are conflicting and information on outcome predictors is scarce. In this 
retrospective study, we analysed functional outcome in 517 patients with stroke and thrombolysis 
and/or thrombectomy treated at the University Hospital Zurich. We compared clinical factors and 
performed multivariate logistic regression analyses investigating the effect of outcome predictors 
according to stroke territory. Of the 517 patients included, 80 (15.5%) suffered a posterior 
circulation stroke (PCS). PCS patients were less often female (32.5% vs. 45.5%, p = 0.031), received 
thrombectomy less often (28.7% vs. 48.3%, p = 0.001), and had lower median admission NIHSS 
scores (5 vs. 10, p < 0.001) as well as a better median three months functional outcome (mRS 1 vs. 2, 
p = 0.010). Predictors for functional outcome were admission NIHSS (OR 0.864, 95% CI 0.790–0.944, 
p = 0.001) in PCS and age (OR 0.952, 95% CI 0.935–0.970, p < 0.001), known symptom onset (OR 1.869, 
95% CI 1.111–3.144, p = 0.018) and admission NIHSS (OR 0.840, 95% CI 0.806–0.876, p < 0.001) in ACS. 
Acutely treated PCS and ACS patients differed in their baseline and treatment characteristics. We 
identified specific functional outcome predictors of thrombolysis and/or thrombectomy success for 
each stroke territory.
Stroke is the second leading cause of death  worldwide1, with 80–87% of strokes being  ischaemic2–4. Ischaemic 
strokes can be further specified according to their vascular territory as anterior (ACS, from internal carotid 
arteries) and posterior circulation ischaemic stroke (PCS, from vertebral arteries). About 20% of the cerebral 
blood flow is directed through the posterior cerebral circulation, resulting in approximately one fifth of ischaemic 
strokes being  PCS2. Usually PCS and ACS are associated with clinically distinct  symptoms5. This is intuitively 
clear since different brain regions are affected. However, in addition, several previous studies comparing PCS 
and ACS have proposed different patient characteristics regarding demographics, cardiovascular risk factors and 
stroke aetiology specific for the stroke  territory5–9. Overall, patients suffering a posterior circulation ischaemic 
stroke tend to be  younger6–8,10 and more often male compared to ACS  patients5–8,11. Diabetes was more frequent 
in PCS, whereas atrial fibrillation was more common in  ACS6–8,11. Stroke aetiologies have been reported to be 
unevenly distributed in PCS and ACS, though results vary a lot between  studies5,8,9. The reasons for these dif-
ferences remain elusive.
Acute ischaemic stroke can be treated with thrombolysis and thrombectomy to restore perfusion of the brain. 
Both methods are safe and effective in  ACS12 as well as in  PCS13–16. However, the success of both treatments 
depends on patient factors, stroke severity as well as time since symptom  onset17. Yet, the National Institutes of 
Health Stroke Scale (NIHSS) which is commonly used to quantify stroke severity, incompletely depicts stroke 
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symptoms of the posterior  circulation18. Therefore, this scale may not be a suited tool to judge symptom severity 
or predict treatment success. The modified Rankin Scale (mRS) has been established to evaluate the degree of 
disability and functional outcome after  stroke19,20. Comparisons of functional outcome after acute stroke treat-
ment between PCS and ACS yielded conflicting results, with most studies proposing similar outcomes for both 
stroke  territories5,13,14,21–24 and some finding a higher rate of disability in either  PCS8 or  ACS25. Since patients 
with PCS seem to be different from those with ACS, this implies that outcome may be determined by different 
factors for these vascular territories. However, information on specific outcome predictors according to stroke 
territory is  scarce14,15,21.
The aim of this analysis was to search for different patient profiles in patients with PCS versus ACS subjected 
to thrombolysis and/or thrombectomy and therefore deemed significantly affected in an early time window. One 
goal was to identify specific predictors for the affected vascular territory by stroke. Additionally, we wanted to 
investigate if specific outcome predictors exist for the different vascular stroke territories.
Results
Patient characteristics. 3594 patients with suspected stroke treated between 2014 and 2017 were screened 
from the Swiss Stroke Registry at the University Hospital of Zurich. Out of these patients, 583 fulfilled the inclu-
sion criteria of ischaemic stroke treated with thrombolysis and/or thrombectomy and either written informed 
consent or no objection to data research according to the ethics protocol (KEH-ZH-Nr. 2014-0304). 21 patients 
were excluded due to missing information on three months mRS, another 26 patients due to concurrent stroke 
in both the posterior and anterior cerebral territory, and 19 patients due to stroke treatment after > 24 h (n = 13) 
or in-hospital events (n = 6). In the end, 517 patients were included in this data analysis. Out of the 517 patients, 
80 (15.5%) had PCS and 437 (84.5%) had ACS.
Demographic data and information on the patients’ medical history are shown in Table 1. There was no differ-
ence in age between PCS and ACS patients (69.4 years, IQR 24 vs. 72.3 years, IQR 20, p = 0.187). The proportion 
of female patients was significantly lower in PCS compared to ACS (32.5% versus 45.5%, p = 0.031). PCS patients 
less often suffered from diabetes (5.0% vs. 14.4%, p = 0.021) and atrial fibrillation (16.3% vs. 29.7%, p = 0.013). 
Other cardiovascular risk factors including previous cardiovascular events as well as pre-stroke medication did 
not differ between the two groups.
Stroke aetiologies were similar in both patient groups. The type of acute stroke treatment was significantly 
different between PCS and ACS (p = 0.005). As expected, PCS patients less often received mechanical thrombec-
tomy (28.7% vs. 48.3%, p = 0.001). Treatment times including onset-to-door time (ODT), onset-to-treatment time 
(OTT) or last-time-seen-normal-to-door and last-time-seen-normal-to-treatment time, for unknown symptom 
onset respectively, as well as the door-to-treatment time (DTT) were similar for both stroke territories except 
for patients with known symptom onset who were treated with intravenous thrombolysis. In this subgroup, 
PCS patients had a longer OTT compared to ACS patients (median time 151.5 min, IQR 98 vs. 128 min, IQR 
68, p = 0.014) (Table 2).
There were no differences regarding vital parameters on admission between PCS and ACS. PCS patients 
presented with a lower NIHSS on admission (median NIHSS 5, IQR 8 vs. 10, IQR 11, p < 0.001) and had a lower 
NIHSS after 24 h (median NIHSS 2, IQR 5 vs. 5, IQR 9, p < 0.001). The pre-stroke modified Rankin Scale was 
similar for both groups (median pre-mRS, 0 IQR 0 vs. 0 IQR 0, p = 0.974). PCS patients had a lower mRS at 90 
days (median mRS90d 1, IQR 2 vs. 2, IQR 4, p = 0.010) and good outcome, defined as mRS90d ≤ 2, was more 
frequent among PCS patients (76.3% vs. 62.9%, p = 0.022). There was no difference in the duration of hospital 
stay or in the occurrence of complications within the 90 days follow-up period between the two stroke territories 
(Table 3).
Vascular results including occlusion or stenosis in the suspected ischaemic territory did not differ between 
PCS and ACS (Table 4).
Predictors for posterior versus anterior circulation stroke territory. We investigated the influence 
of age, sex, diabetes, atrial fibrillation, hypertension and prior stroke or TIA on the stroke territory to seek out 
potential predictors for PCS versus ACS. The factors were selected due to the observed differences in their occur-
rence in PCS vs. ACS in previous studies, their overall frequency in the population and their prognostic impact. 
In the multivariate binary logistic regression analysis, both diabetes (OR 0.349, 95% CI 0.122–0.994, p = 0.049) 
and atrial fibrillation (OR 0.496, 95% CI 0.263–0.936, p = 0.030) made PCS less likely than ACS (Table 5).
Predictors for good functional outcome in posterior and anterior circulation stroke. Age, sex, 
medical history of diabetes, atrial fibrillation, hypertension, dyslipidaemia, smoking, previous stroke or TIA, 
the admission NIHSS, knowledge of symptom onset and the onset-to-treatment time were examined for their 
predictive impact on good functional outcome defined as ≤ 2 on the mRS at 90 days after stroke, for each stroke 
territory respectively.
In the multivariate binary logistic regression analysis, the admission NIHSS remained the only predictor for 
functional outcome in PCS with a higher NIHSS making a good functional outcome less likely (OR 0.864, 95% 
CI 0.790–0.944, p = 0.001). For ACS, the multivariate binary logistic regression analysis showed that an increase 
in age (OR 0.952, 95% CI 0.935–0.970, p < 0.001) and an increase in the admission NIHSS (OR 0.840, 95% CI 
0.806–0.876, p = 0.000) made a good functional outcome less likely. On the other hand, a known symptom onset 
was associated with a good functional outcome (OR 1.869, 95% CI 1.111–3.144, p = 0.018) (Table 6).
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Discussion
Stroke location and affected vascular territory crucially determine clinical symptoms. However, in addition to 
these anatomical differences, our results support the hypothesis of different patient baseline characteristics for 
PCS versus ACS, even for acute stroke patients all selected for thrombolysis and/or thrombectomy. In our descrip-
tive analysis, we found differences in patients with PCS versus ACS. Multivariate logistic regression analyses 
revealed that the presence of diabetes and atrial fibrillation made an ACS more likely than a PCS. Furthermore, 
specific predictors of favourable outcome were different in ACS (younger age, lower admission NIHSS, known 
symptom onset) and PCS (lower admission NIHSS).
In our cohort of patients with ischaemic stroke receiving acute stroke therapy, 15.5% of strokes occurred in 
the posterior cerebral circulation. This proportion is similar to observations in treatment-only  cohorts13,15,22. PCS 
patients in our cohort were more often male, less often suffering from diabetes or atrial fibrillation, had lower 
admission NIHSS scores compared to ACS and less often underwent mechanical thrombectomy. Moreover, we 
observed a better three months functional outcome after acute stroke therapy in PCS. Our findings are in line 
with a recent data analysis from the SITS-MOST (Safe Implementation of Thrombolysis in Stroke Monitoring 
Study) registry, which had intracerebral haemorrhage (ICH) after intravenous thrombolysis as primary outcome, 
and found less ICH in patients with PCS strokes, along with a higher proportion of patients reaching functional 
independence (mRS 0–2) at 3  months16.
Table 1.  Patient clinical characteristics. Clinical characteristics of all 517 patients and patient groups 
according to stroke territory, anterior circulation stroke (ACS) and posterior circulation stroke (PCS). Data are 
expressed as number of patients (n) and percentages or median and interquartile range (IQR). TIA indicates 
transient ischaemic attack; DOACs, direct oral anticoagulants (i.e. Rivaroxaban, Dabigatran, Apixaban). P 
values were obtained according to Mann–Whitney U test, Pearson’s Chi-squared test and Fisher’s Exact test, 
where appropriate. P values < 0.05 are shown in bold.
All
n = 517 (%)
ACS
n = 437 (%)
PCS
n = 80 (%) P value
Demographic data
Age, median years (IQR) 71.9 (20) 72.3 (20) 69.4 (24) 0.187
Female, n (%) 225 (43.5) 199 (45.5) 26 (32.5) 0.031
Medical history and risk factors, n (%)
Stroke and/or TIA 70 (13.5) 57 (13.0) 13 (16.3) 0.441
Intracranial haemorrhage 6 (1.2) 6 (1.4) 0 (0) 0.597
Hypertension 349 (67.5) 299 (68.4) 50 (62.5) 0.299
Diabetes 67 (13.0) 63 (14.4) 4 (5.0) 0.021
Dyslipidaemia 292 (56.5) 248 (56.8) 44 (55.0) 0.772
Smoking 108 (20.9) 87 (19.9) 21 (26.3) 0.200
Atrial fibrillation 143 (27.7) 130 (29.7) 13 (16.3) 0.013

















Peripheral artery disease 31 (6.0) 26 (5.9) 5 (6.3) 0.803
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We could not confirm the observation of PCS patients being younger than ACS  patients8,13,15,26. Similar to 
others, we found more men among patients suffering a  PCS5,8,9,15,26,27. The reason for this sex discrepancy is 
unclear. Vavilala et al.’s findings of a lower autoregulation capacity in the basilar artery in teenage boys compared 
to girls might to some extent offer an explanation of the male preponderance in posterior circulation  stroke28. 
Atrial fibrillation was previously found more frequently in patients with  ACS5,8,9,15. On the other hand, the lower 
incidence of diabetes in PCS contrasts with previous observations which indicated an equal prevalence of dia-
betes in PCS and  ACS5,13,15,21,22,26,27 or even a higher prevalence in PCS  patients7–9,29. While we did not find any 
differences between PCS and ACS patients concerning pre-stroke medication, other studies suggest a greater use 
of  antihypertensives5 and platelet inhibitors in  ACS10,22. In our descriptive analysis, there were no statistically 
significant differences in stroke aetiology between the two stroke territories. Previous studies detected a higher 
incidence of cardiac stroke in ACS and small artery disease in  PCS5,22,27. These discrepancies are likely due to 
different patient cohorts, since we considered only patients receiving acute stroke treatments, thus excluding 
very mild strokes.
The greater frequency of thrombectomy in ACS patients was expected. IAT is safe and effective in PCS and 
in  ACS14. The longer onset to treatment time (OTT) in PCS patients with known symptom onset who received 
thrombolysis was related to the onset-to-door (ODT) rather than the door-to-treatment time (DTT). Several 
studies observed longer OTT in PCS compared to ACS receiving  IVT14,15,22,26 and elongated ODT in PCS regard-
less of acute treatment or knowledge of symptom  onset5,30. Possible explanations for the pre-hospital time delay 
in PCS are less obvious stroke symptoms (such as vertigo and double vision compared to hemiplegia or aphasia) 
Table 2.  Stroke aetiology and acute treatment information. Information on stroke aetiology and acute stroke 
treatment of all 517 patients and patient groups according to stroke territory, ACS and PCS. *Marked variables 
only contain patients with known symptom onset versus **unknown symptom onset. Data are expressed as 
number of patients (n) and percentages or median and interquartile range (IQR). IVT indicates intravenous 
thrombolysis; IAT, intra-arterial therapy. P values were obtained according to Mann–Whitney U test, Pearson’s 
Chi-squared test and Fisher’s Exact test, where appropriate. P values < 0.05 are shown in bold.
All
n = 517 (%)
ACS
n = 437 (%)
PCS
n = 80 (%) P value
Stroke aetiology, n (%) 0.229
Large artery atherosclerosis 72 (13.9) 58 (13.3) 14 (17.5)
Cardiac 189 (36.6) 169 (38.7) 20 (25.0)
Lacunar 17 (3.3) 14 (3.2) 3 (3.8)
Dissection 27 (5.2) 22 (5.0) 5 (6.3)
Rare or multiple causes 18 (3.5) 14 (3.2) 4 (5.0)
Unknown cause 194 (37.5) 160 (36.6) 34 (42.5)
Acute stroke treatment, n (%) 0.005
Only IVT 283 (54.7) 226 (51.7) 57 (71.3)
Only IAT 75 (14.5) 67 (15.3) 8 (10.0)
Both IVT and IAT 159 (30.8) 144 (33.0) 15 (18.8)
IAT (with or without IVT) 234 (45.3) 211 (48.3) 23 (28.7) 0.001
Treatment times, median minutes (IQR)
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Table 3.  Patient characteristics—scores and course of disorder. Scores and course of disorder of all 517 
patients and patient groups according to stroke territory, ACS and PCS. Data are expressed as number of 
patients (n) and percentages or median and interquartile range (IQR). BP indicates blood pressure; NIHSS, 
National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; ICH, intracranial haemorrhage. P 
values were obtained according to Mann–Whitney U test, Pearson’s Chi-squared test and Fisher’s Exact test, 
where appropriate. P values < 0.05 are shown in bold.
All
n = 517 (%)
ACS
n = 437 (%)
PCS
n = 80 (%) P value
Vital parameters on admission, median (IQR)
Systolic BP, mmHg 153 (31) 154 (32) 151 (39) 0.449


































Pre-mRS 0 (0) 0 (0) 0 (0) 0.974
mRS at 90d 1 (3) 2 (4) 1 (2) 0.010
Good outcome (mRS90d ≤ 2), n (%) 336 (65.0) 275 (62.9) 61 (76.3) 0.022









Complications within 90 days, n (%)
Recurrent stroke 6 (1.2) 6 (1.4) 0 (0) 0.597
Symptomatic ICH 13 (2.5) 13 (3.0) 0 (0) 0.236
Death in Hospital 31 (6.0) 27 (6.2) 4 (5.0) 1.000
Table 4.  Patient characteristics—imaging. Imaging characteristics of all 517 patients and patient groups 
according to stroke territory, ACS and PCS. Data are expressed as number of patients (n) and percentages. 
CT indicates computer tomography; MRI, magnetic resonance imaging; PWI, perfusion weighted imaging. 
P values were obtained according to Pearson’s Chi-squared test and Fisher’s Exact test, where appropriate. P 
values < 0.05 are shown in bold.
All
n = 517 (%)
ACS
n = 437 (%)
PCS
n = 80 (%) P value
First Imaging, n (%) 0.702
CT 434 (83.9) 368 (84.2) 66 (82.5)
MRI 83 (16.1) 69 (15.8) 14 (17.5)
Vascular result, n (%) 0.090





















Table 5.  Binary logistic regression analysis—predictors for PCS vs. ACS territory. Multivariate stepwise 
backward binary logistic regression analysis of predictors for stroke in the posterior compared to the anterior 
cerebral circulation (PCS vs. ACS). The influence of age, sex, diabetes, atrial fibrillation, hypertension and prior 
stroke or TIA on the stroke territory was investigated. Data are expressed as odds ratio and the 95% CI of the 
odds ratio. 95% CI indicates 95% confidence interval; MH, medical history. P values < 0.05 are shown in bold.
Odds ratio 95% CI P value
Stepwise multivariate binary logistic regression analysis
MH diabetes 0.349 0.122–0.994 0.049
MH atrial fibrillation 0.496 0.263–0.936 0.030
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and less severe neurological symptoms as judged from the lower admission NIHSS in PCS. However, even though 
a subgroup of PCS patients arrived later at the hospital, subsequently treated with longer OTT, there was no 
disadvantage regarding functional outcome at three months detectable in our analysis.
In line with our analysis, the admission NIHSS is often lower in  PCS5,9,11,13,21,22,26,27, since this score is designed 
to assess ACS-induced  deficits18. In our cohort, the pre-stroke mRS, which describes functional impairment, was 
equally low in PCS and ACS. Interestingly, the mRS after 90 days was lower in PCS, and functional independence 
defined as mRS ≤ 2 after 90 days was significantly more frequent in PCS patients (76.3% vs. 62.9%, p = 0.010). 
Complications within three months follow-up including recurrent strokes and symptomatic intracranial haem-
orrhage (ICH) occurred with similar frequencies in PCS and ACS.
We confirmed differences in patient characteristics and treatment variables between ACS and PCS. However, 
one major goal of our study was to explore variables that would favour the occurrence of ACS versus PCS, and 
subsequently, to find variables that would indicate 3-months disability as a measure of treatment success for 
either territory.
Some studies have reported that atrial fibrillation occurs more frequently in ACS, especially in women above 
the age of 80  years31, while the evidence regarding diabetes as well as further predictors for stroke territory—such 
as sex, cardiovascular risk factors and stroke mechanism—is  conflicting5,9. We found that both diabetes and atrial 
fibrillation favoured the presence of ACS to PCS. There was no evidence that age, sex, hypertension and prior 
stroke or TIA had an effect on the presence of ACS vs. PCS.
In addition, predictors for 3-months disability were different for patients suffering ACS vs. PCS. The NIHSS on 
admission was the only predictor for functional outcome in PCS. In contrast, in ACS, in addition to the admission 
NIHSS, known symptom onset and age predicted outcome after stroke and acute stroke therapy. The correlation 
of the admission NIHSS with outcome in acutely treated patients has been described before for  PCS14,32 as well 
as for ACS  patients21,33. Many other factors have been proposed to influence outcome after stroke, but either no 
distinction was made between stroke  territories13,24,29 or acutely treated and untreated patients were investigated 
as one  entity8. In our analysis, we additionally considered sex, medical history of diabetes, hypertension, dyslipi-
daemia, smoking, previous stroke or TIA and onset to treatment time, which, however, showed no significant 
effect on functional outcome neither in ACS nor in PCS patients.
It is interesting that the admission NIHSS independently predicted outcome in PCS, although its validity for 
the assessment of stroke severity in PCS has been  questioned34. We only considered patients with acute stroke 
treatment in our analysis. Therefore, the median admission NIHSS score may have been higher compared to 
non-treated or mixed cohorts, which could have influenced its predictive value for PCS patients. A known 
symptom onset facilitates a faster identification of stroke symptoms and prompt therapeutic interventions, ide-
ally resulting in a better functional outcome. However, the OTT did not prove to be an independent outcome 
predictor in either PCS or ACS. For ACS, knowledge on symptom onset may have outweighed the influence of 
the OTT on the mRS in multivariate regression analysis. For PCS, the OTT has been shown to be less crucial 
in  thrombolysis35 which might explain the lack of influence of known symptom onset and OTT on functional 
outcome in PCS patients.
Our findings imply that differences in patient characteristics between PCS and ACS exist in stroke patients 
that qualify for acute stroke treatment. Fortunately, the familiar issue of elongated time intervals in the workup 
of PCS was not very pronounced in our analysis. Although the NIHSS might not entirely capture stroke severity 
in PCS, its assessment might have prognostic value. Against our expectations and in contrast to Dornak et al.’s 
findings of a negative correlation of age and outcome in thrombolysed PCS  patients15, in our analysis older age 
indicated worse outcome in ACS patients, while age did not correlate with functional outcome in PCS. While an 
existing influence could be concealed by the limited number of patients, this observation should be considered in 
assessing the eligibility for acute stroke treatment for PCS. In our analysis, we only considered ischaemic stroke 
patients receiving acute stroke treatment to evaluate outcome of these treatments in patients with PCS versus 
Table 6.  Binary logistic regression analysis—predictors for good outcome in PCS and ACS. Multivariate 
stepwise backward binary logistic regression analysis for outcome in posterior circulation stroke (PCS) and 
anterior cerebral circulation stroke (ACS), separately. Age, sex, medical history of diabetes, atrial fibrillation, 
hypertension, dyslipidaemia, smoking, previous stroke or TIA, the admission NIHSS, knowledge of symptom 
onset and the onset-to-treatment time were examined for their predictive impact on good functional outcome 
defined as ≤ 2 on the mRS at 90 days. Data are expressed as odds ratios and the 95% CI of the odds ratios. 95% 
CI indicated 95% confidence interval; NIHSS, National Institutes of Health Stroke Scale. P values < 0.05 are 
shown in bold.
Odds ratio 95% CI P value
Stepwise multivariate binary logistic regression analysis
PCS
 Admission NIHSS 0.864 0.790–0.944 0.001
ACS
 Age 0.952 0.935–0.970  < 0.001
 Admission NIHSS 0.840 0.806–0.876  < 0.001
 Known symptom onset 1.869 1.111–3.144 0.018
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ACS. We did not compare treated with untreated patient groups, as our goal was not to reaffirm the efficacy of 
thrombolysis and thrombectomy in ACS and  PCS12–16.
One limitation of this analysis is its relatively small number of patients, especially in the subgroup of PCS. This 
might have contributed to the fact that less outcome predictors were identified in multivariate regression analysis 
for PCS compared to ACS. In addition, our analysis only included patients from a single centre and the data 
analysis was performed retrospectively. The strength of our analysis lies in the large number of variables that were 
compared between the two patient groups, including pre- and post-stroke as well as treatment-specific factors.
Overall, our analysis of acutely treated stroke patients supports the hypothesis of different patient profiles for 
posterior versus anterior circulation strokes. We identified predictors for the stroke territory as well as predic-
tors for functional outcome for each vascular territory respectively. Knowledge about specific characteristics of 
patients with ACS and PCS including outcome predictors of thrombolysis and thrombectomy in these patients 
may aid in improving treatment decisions in acute stroke.
Methods
Patients. This retrospective data analysis contains patient data from the Swiss Stroke Registry of the Uni-
versity Hospital Zurich (USZ) from 2014 until the end of 2017. The Swiss Stroke Registry enlists every patient 
presenting with suspected stroke (< 7 days before admission) at the USZ. Data were collected by the treating 
physician. Stroke treatments at the USZ Stroke Center were performed according to the current guidelines of the 
European Stroke  Organization36. Accordingly, intravenous thrombolysis was performed within 4.5 h of symp-
tom onset, and thrombectomy within 6 h of symptom onset in patients without contraindications. In some 
patients, treatment windows were extended based on advanced imaging such as small core and/or mismatch. All 
data was reviewed from the electronic patient files of the clinical information system and corrected if missing or 
inconclusive. Inclusion criteria were ischaemic stroke and acute stroke therapy with intravenous thrombolysis 
or intra-arterial therapy, i.e. mechanical thrombectomy. Haemorrhagic strokes and transient ischaemic attacks 
were excluded. Patients with onset-to-treatment times greater 24 h, in-hospital events and patients with missing 
information on three months functional outcome were excluded. Consent to research was obtained as written 
informed consent from all participants and/or their legal guardians or waived according to the ethics protocol 
KEH-ZH-Nr. 2014-0304 “Bildgebungsprädikatoren für die Erholung nach Schlaganfall (PREDICT)”, approved 
by the ethics committee Kantonale Ethikkommission Kanton Zürich (KEK ZH); and all methods were carried 
out in accordance with relevant guidelines and regulations.
Patients were divided into two groups according to their stroke territory in posterior (PCS) versus anterior 
circulation ischaemic stroke (ACS) by clinical and radiological findings. ACS was defined as a stroke in the ter-
ritory supplied by the anterior choroidal arteries, the medial cerebral arteries and the anterior cerebral arteries 
together with their supplying vascular territory. PCS was likewise defined as a stroke in the vascular territory of 
the vertebral arteries, the basilar artery and the posterior cerebral arteries. To obtain homogenous comparable 
groups, patients with concurrent posterior and anterior circulation strokes were excluded. All patients received 
acute stroke therapy by either intravenous thrombolysis (IVT) or intra-arterial therapy (IAT) or a combination 
of both treatments. Stroke severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) which 
captures the degree of neurological deficits in acute ischaemic stroke patients, ranging from 0—no neurological 
deficits—to a total of 42  points37. In the Swiss Stroke Registry, the NIHSS is assessed on admission and after 24 h. 
Both pre-stroke disability and functional outcome were quantified by the modified Rankin Scale (mRS)38 which 
assesses functional independence, ranging from 0—no constraint—to 6—death. In the Swiss Stroke Registry, 
the mRS is assessed retrospectively on admission and three months after stroke. A mRS ≤ 2 represents functional 
independence. Stroke aetiology was assessed according to ASTRAL, the Acute STroke Registry and Analysis of 
 Lausanne5, which is based on the TOAST  classification39.
Statistical analyses. Statistical analyses were performed using IBM SPSS Statistics 25. The two patient 
groups ACS and PCS were compared regarding demographic and clinical characteristics. Continuous variables 
are shown as median and interquartile range. Nominal variables are expressed as fractions and percentages. The 
Mann–Whitney U test for two independent samples was performed to compare continuous variables between 
the two groups. The Chi-squared test and the Fisher’s Exact test (for expected values less than five) were con-
ducted to compare nominal variables. Binary logistic regression analyses were performed including variables in 
a stepwise backward manner to identify predictors for posterior versus anterior circulation stroke territory and 
to investigate predictors for functional outcome (mRS 90d) for each stroke territory. The mRS was dichotomized 
and good outcome was defined as a score of ≤ 2 on the mRS at 90 days. Results are expressed as odds ratios and 
the 95% confidence interval (CI) of the odds ratios. A two-sided significance level of alpha = 0.05 was considered. 
Data are shown in tables.
Data availability
All data generated or analysed during this study are included in this published article. The datasets generated 
during and/or analysed during the current study are available in anonymized form from the corresponding 
author upon reasonable request.
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